Overview
Elizabeth Layhe is an Oncologist and a Hematologist in Lansing, Michigan. Dr. Layhe is rated as an Experienced provider by MediFind in the treatment of Breast Cancer in Men. Her top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Inflammatory Breast Cancer. Dr. Layhe is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Regents Of The University Of Michigan
Monika Burness is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Burness is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. Her top areas of expertise are Breast Cancer, Breast Cancer in Men, Angiosarcoma, and Paget Disease of the Breast. Dr. Burness is currently accepting new patients.
Cortney Jones is a Hematologist Oncology specialist and a Hematologist in Commerce Township, Michigan. Dr. Jones is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Breast Cancer in Men, Laryngeal Cancer, Familial Colorectal Cancer, Congenital Antithrombin 3 Deficiency, and Embolectomy. Dr. Jones is currently accepting new patients.
Regents Of The University Of Michigan
Jeffrey Smerage is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Smerage is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Layhe isDistinguished. Learn about Breast Cancer.
- Colorectal CancerDr. Layhe isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Layhe isDistinguished. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Layhe isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Layhe isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Immune ThrombocytopeniaDr. Layhe isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AngiosarcomaDr. Layhe isAdvanced. Learn about Angiosarcoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Layhe isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Deep Vein ThrombosisDr. Layhe isAdvanced. Learn about Deep Vein Thrombosis.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Eosinophilic PneumoniaDr. Layhe isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Layhe isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Layhe isExperienced. Learn about Acute Promyelocytic Leukemia.